Ryan Kole

Securing funding for intranasal therapeutics has never been more competitive. As investors become increasingly selective and funding tightens, developers must show not only strong science but also a compelling commercial narrative, differentiated positioning, and evidence of de-risking across development. Designed for biotech founders, R&D leaders, program directors, and BD teams advancing novel intranasal modalities, this interactive workshop, led by active biotech investors and seasoned fundraisers, will help participants transform their programs into investment-ready opportunities. Through practical frameworks and real-world insights from successful

raises, attendees will learn how to communicate scientific value, articulate a credible regulatory and commercial pathway, and craft a compelling story that resonates with venture capital, angels, and strategic partners.

This workshop will explore:

• Crafting a Compelling Scientific and Commercial Narrative: Learn to communicate the therapeutic rationale, unmet need, differentiation, and market opportunity behind your nasal product
• De-Risking Strategies that Matter to Investors: Understand what funders actually look for
• Positioning for Funding Success: Benefit from networking and group project activities, ending in a Shark Tank–style competition